JP2929943B2 - Calcitriol intermediate and process for producing the same - Google Patents

Calcitriol intermediate and process for producing the same

Info

Publication number
JP2929943B2
JP2929943B2 JP21394494A JP21394494A JP2929943B2 JP 2929943 B2 JP2929943 B2 JP 2929943B2 JP 21394494 A JP21394494 A JP 21394494A JP 21394494 A JP21394494 A JP 21394494A JP 2929943 B2 JP2929943 B2 JP 2929943B2
Authority
JP
Japan
Prior art keywords
compound
formula
ether
solution
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP21394494A
Other languages
Japanese (ja)
Other versions
JPH0873390A (en
Inventor
國郎 小笠原
香月 田積
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daisoo Kk
Original Assignee
Daisoo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daisoo Kk filed Critical Daisoo Kk
Priority to JP21394494A priority Critical patent/JP2929943B2/en
Publication of JPH0873390A publication Critical patent/JPH0873390A/en
Application granted granted Critical
Publication of JP2929943B2 publication Critical patent/JP2929943B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Epoxy Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は骨粗鬆症その他の疾病に
対する治療薬カルシトリオール及びその関連のビタミン
誘導体を製造する際の後記式9で示されるカルシトリオ
ールのA環部に相当する重要中間体を製造するための新
規な化合物及びその製法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is to produce an important intermediate corresponding to the A-ring of calcitriol represented by the following formula 9 when producing a therapeutic drug calcitriol and related vitamin derivatives for osteoporosis and other diseases. And a process for producing the same.

【0002】[0002]

【従来の技術】カルシトリオール及びその関連のビタミ
ン誘導体は骨粗鬆症その他の疾病に対する治療薬として
用いられており、この製法について、とくにカルシトリ
オールのA環部分の合成方法についてより効率的な方法
の開発が求められてきた。
2. Description of the Related Art Calcitriol and its related vitamin derivatives have been used as therapeutic agents for osteoporosis and other diseases. The development of a more efficient method for this method, particularly for the synthesis of the A-ring portion of calcitriol, has been required. I have been asked.

【0003】後記式9に示されるカルシトリオールのA
環部に相当する化合物の製法は知られている(E.G.Bagg
iolini等、J.Am.Chem.Soc.,104,2945(1982))。また、
本発明においてA環部に相当する化合物の中間体である
式7cに代表される鎖化合物の製法も知られている(B.
M.Trost 等、J.Am.Chem.Soc.,114,9836(1992))。
[0003] The A of calcitriol represented by the following formula 9
A method for producing a compound corresponding to the ring portion is known (EGBagg
iolini et al., J. Am. Chem. Soc., 104, 2945 (1982)). Also,
In the present invention, a method for producing a chain compound represented by the formula 7c, which is an intermediate of a compound corresponding to the ring A, is also known (B.
M. Trost et al., J. Am. Chem. Soc., 114, 9836 (1992)).

【0004】[0004]

【発明が解決しようとする課題】上記公知の方法は工業
的には問題となる点が多くより優れた方法の開発が求め
られていた。即ち前者の方法ではd−カルボンを原料と
し、立体特異的にエポキシ化した後ホーナー・エモンス
反応でジエチル(カルボキシエチル)リン酸エステルの
カルバニオンと反応させ、生じたα,β−不飽和エステ
ルの9:1のZ体・E体混合物をシリカゲル・カラムで
分離し, Z体を除去し、エポキシ基を開環後、ジアセテ
ートとした後イソプロペニル基をアセチル基、次いでア
セテートへと酸化し、トリアセテートとし、加水分解し
てトリオールとした後、2級水酸基のみt−ブチルジメ
チルシリル基で保護し、脱水してエキソメチレン基に変
換する方法で式 9a,9bで示される化合物が合成さ
れているが、工程も長く、途中の反応も副反応を起こさ
ないように非常に注意を要するプロセスである。
The above-mentioned known methods have many industrial problems and there has been a demand for the development of a better method. That is, in the former method, d-carboxyl is used as a raw material, sterically-specifically epoxidized, and then reacted with a carbanion of diethyl (carboxyethyl) phosphate by a Horner-Emmons reaction. : The Z-isomer / E-isomer mixture is separated by a silica gel column, the Z-isomer is removed, the epoxy group is opened, the diacetate is formed, the isopropenyl group is oxidized to an acetyl group, then to acetate, and the triacetate is removed. After hydrolysis to form a triol, the compounds represented by the formulas 9a and 9b have been synthesized by a method in which only the secondary hydroxyl group is protected with a t-butyldimethylsilyl group and dehydrated to convert it into an exomethylene group. This is a process that requires a great deal of care so that the steps are long and the reaction in the middle does not cause a side reaction.

【0005】後者の方法では中間体の3−ヒドロキシ−
5−t−ブチルジフェニルシロキシオクタ−7−イン−
1−エンのシン体、アンチ体を分離しなければならず、
経済効率を上げるためにはシン体の3位の水酸基を光延
法で立体反転させてアンチ体にする必要があり、さらに
上記のシン体のラセミ混合物のうち(+)体を動力学的
な分割法の原理で選択的に不斉エポキシ化して除去し、
未反応(−)体を回収する必要があり、光学純度の良い
製品を大量に得ることは容易ではなく、工業的な製法と
しては操作が煩雑な欠点があった。
In the latter method, the intermediate 3-hydroxy-
5-t-butyldiphenylsiloxyoct-7-yn-
The syn-form and anti-form of 1-ene must be separated,
In order to increase the economic efficiency, it is necessary to invert the 3-position hydroxyl group of the syn-form by the Mitsunobu method to obtain the anti-form, and furthermore, the (+)-form of the racemic mixture of the syn-form is subjected to dynamic resolution. Asymmetric epoxidation and removal by the principle of the method,
It is necessary to recover the unreacted (-) form, and it is not easy to obtain a large amount of a product with good optical purity, and there is a disadvantage that the operation is complicated as an industrial production method.

【0006】[0006]

【課題を解決するための手段】本発明者は上記に鑑み、
効率良くまた副生成物のすくない、簡単な反応経路でカ
ルシトリオール及びその関連のビタミン誘導体のA環部
の重要中間体、即ち式8a,8bおよび9a,9bで表
される化合物を得る方法について鋭意検討した結果、式
1で表される化合物S−5−ヒドロキシ−オクタ−2,
7−ジイン−1−オールおよびそのシリル誘導体を原料
に下記の反応経路(I)に従い、目的とする上記の化合
物を得る新たな方法を見いだした。下記反応経路中、TM
S はトリメチルシリル基、THP はテトラヒドロピラニル
基、TBS はt−ブチルジメチルシリル基をそれぞれ表
す。
In view of the above, the present inventor has considered,
The present invention is directed to a method for efficiently obtaining a key intermediate in the A-ring of calcitriol and its related vitamin derivatives, that is, the compounds represented by formulas 8a and 8b and 9a and 9b, by a simple reaction route with little by-products. As a result of the examination, the compound S-5-hydroxy-octa-2, represented by the formula 1,
According to the following reaction route (I) using 7-diyn-1-ol and its silyl derivative as starting materials, a new method for obtaining the above-mentioned compound of interest has been found. In the following reaction pathway, TM
S represents a trimethylsilyl group, THP represents a tetrahydropyranyl group, and TBS represents a t-butyldimethylsilyl group.

【0007】反応経路(I)Reaction pathway (I)

【化4】 Embedded image

【0008】本発明は下記の式1で表される化合物S−
5−ヒドロキシ−オクタ−2,7−ジイン−1−オール
とそのシリル誘導体及びその製法である。
The present invention provides a compound S- represented by the following formula 1.
5-hydroxy-octa-2,7-diyn-1-ol, its silyl derivative and its preparation.

【0009】[0009]

【化5】 (但しR1 は水素もしくはトリメチルシリル基を,R2
は水素もしくは t−ブチルジメチルシリル基を, R3
テトラヒドロピラニル基もしくは水素を表す。)
Embedded image (However, R 1 represents hydrogen or a trimethylsilyl group; R 2
Represents hydrogen or a t-butyldimethylsilyl group, and R 3 represents a tetrahydropyranyl group or hydrogen. )

【0010】以下反応経路Iによって本発明を説明す
る。式1で表される本発明の化合物S−5−ヒドロキシ
−オクタ−2,7−ジイン−1−オールとそのシリル誘
導体は次のようにして製造することができる。即ち、プ
ロパルギルテトラヒドロピラニルエーテルから得られる
リチウムアセチリドを式2で表される化合物とトリフル
オロボロン・エーテレート存在下に反応させるとR1
トリメチルシリル基,R2 が水素及びR3 がテトラヒド
ロピラニル基の式1aの化合物が得られる。またR−
5,6−オキシラニルヘキサ−2−イニルテトラヒドロ
ピラニルエーテル(3)をリチウムトリメチルシリルア
セチリドと反応させても上記の1aの化合物を得ること
ができる。
Hereinafter, the present invention will be described with reference to Reaction Scheme I. The compound S-5-hydroxy-octa-2,7-diyn-1-ol of the present invention represented by the formula 1 and its silyl derivative can be produced as follows. That is, when lithium acetylide obtained from propargyl tetrahydropyranyl ether is reacted with a compound represented by the formula 2 in the presence of trifluoroboron etherate, R 1 is a trimethylsilyl group, R 2 is hydrogen and R 3 is a tetrahydropyranyl group. The compound of formula 1a is obtained. Also R-
The compound 1a can also be obtained by reacting 5,6-oxiranylhex-2-ynyltetrahydropyranyl ether (3) with lithium trimethylsilyl acetylide.

【0011】プロパルギルテトラヒドロピラニルエーテ
ルから得られるリチウムアセチリドと式2の化合物の反
応は次のようにして行なうことができる。プロパルギル
テトラヒドロピラニルエーテルを例えばテトラヒドロフ
ラン、ジエチルエーテル、エチレングリコールなどのエ
ーテル類、又はヘキサンなどの炭化水素類を溶媒とし、
メチルリチウム、n−ブチルリチウム、 sec−ブチルリ
チウム、t−ブチルリチウムなどの強塩基の等量以上と
作用させて生成するリチウムアセチリドを式2の化合物
S−5−トリメチルシリル−1,2−オキシラニルペン
タ−4−イン(2)とルイス酸、例えばトリフルオロボ
ロン・エーテレート存在下に反応させると式1aの化合
物が得られる。この反応は−30℃〜− 100℃の低温で行
なうことが望ましい。この反応は触媒なしでも進行する
が、上記のごときルイス酸を添加すると反応が加速され
る。
The reaction of lithium acetylide obtained from propargyl tetrahydropyranyl ether with the compound of the formula 2 can be carried out as follows. Propargyl tetrahydropyranyl ether, for example, tetrahydrofuran, diethyl ether, ethers such as ethylene glycol, or a hydrocarbon such as hexane as a solvent,
Lithium acetylide produced by reacting with an equivalent or more of a strong base such as methyllithium, n-butyllithium, sec-butyllithium, t-butyllithium and the like is converted into a compound S-5-trimethylsilyl-1,2-oxira of formula 2 Reaction of nilpenta-4-yne (2) with a Lewis acid such as trifluoroboron etherate gives the compound of formula 1a. This reaction is desirably performed at a low temperature of -30 ° C to -100 ° C. Although this reaction proceeds without a catalyst, the addition of a Lewis acid as described above accelerates the reaction.

【0012】またR−5,6−オキシラニルヘキサ−2
−イニルテトラヒドロピラニルエーテル(3)とリチウ
ムトリメチルシリルアセチリドとの反応は次のように行
なうことができる。即ち、トリメチルシリルアセチレン
を例えばテトラヒドロフラン、ジエチルエーテル、エチ
レングリコールなどのエーテル類、又はヘキサンなどの
炭化水素類を溶媒とし、メチルリチウム、n−ブチルリ
チウム、 sec−ブチルリチウム、t−ブチルリチウムな
どの強塩基の等量以上と作用させて生成するリチウムア
セチリドを式3の化合物と反応させると式1aの化合物
が得られる。この反応は−30℃〜− 100℃の低温で行な
うことが望ましい。
R-5,6-oxiranylhexa-2
The reaction between -inyltetrahydropyranyl ether (3) and lithium trimethylsilyl acetylide can be carried out as follows. That is, trimethylsilyl acetylene is used as a solvent with ethers such as tetrahydrofuran, diethyl ether and ethylene glycol, or hydrocarbons such as hexane as solvents, and strong bases such as methyl lithium, n-butyl lithium, sec-butyl lithium and t-butyl lithium. Is reacted with a compound of the formula 3 to give a compound of the formula 1a. This reaction is desirably performed at a low temperature of -30 ° C to -100 ° C.

【0013】原料のS−5−トリメチルシリル−1,2
−オキシラニルペンタ−4−イン(2)は高光学純度の
R−エピクロルヒドリンからTetrahedron Asymmetry,3,
853(1992) 記載の方法で製造できる。またもう一つの原
料R−5,6−オキシラニルヘキサ−2−イニルテトラ
ヒドロピラニルエーテル(3)はAngew.Chem.Int.Ed,En
gl.,28,1272(1989) 記載の方法でS−エピクロロヒドリ
ンから製造できる。
The starting material S-5-trimethylsilyl-1,2
-Oxiranyl penta-4-yne (2) was obtained from R-epichlorohydrin of high optical purity by Tetrahedron Asymmetry, 3,
853 (1992). Another raw material, R-5,6-oxiranylhex-2-ynyltetrahydropyranyl ether (3), was obtained from Angew. Chem. Int. Ed, En.
gl., 28, 1272 (1989), from S-epichlorohydrin.

【0014】式1aの化合物から式1b,1c,1dの
化合物への変換は次のように行なう。式1aの化合物を
ジメチルホルムアミド中でイミダゾール存在下にt−ブ
チルジメチルシリルクロライドと反応させるとS−8−
トリメチルシリル−5−t−ブチルジメチルシロキシ−
オクタ−2,7−ジイニルテトラヒドロピラニルエーテ
ル(1b)が得られる。式1bの化合物を触媒量のピリ
ジニウムp−トルエンスルフォナート存在下メタノール
中で加水分解すると一級アルコール(1c)が得られ
る。また式1cの化合物をメタノール中で炭酸カリウム
と加熱するとトリメチルシリル基が脱離して式1dの化
合物を与える。
The conversion of the compound of the formula 1a into the compounds of the formulas 1b, 1c and 1d is carried out as follows. Reaction of the compound of formula 1a with t-butyldimethylsilyl chloride in dimethylformamide in the presence of imidazole gives S-8-
Trimethylsilyl-5-t-butyldimethylsiloxy-
Octa-2,7-diynyltetrahydropyranyl ether (1b) is obtained. Hydrolysis of the compound of formula 1b in methanol in the presence of a catalytic amount of pyridinium p-toluenesulfonate gives the primary alcohol (1c). Heating the compound of formula 1c with potassium carbonate in methanol removes the trimethylsilyl group to give a compound of formula 1d.

【0015】本発明の式1で表される化合物からカルシ
トリオール及びその関連のビタミン誘導体を製造する際
のA環部に相当する重要中間体、即ち式8a,8b及び
式9a,9bで表される化合物の製造は反応経路(I)
に従い、次のようにして行なうことができる。
Important intermediates corresponding to the A ring portion when producing calcitriol and its related vitamin derivatives from the compound represented by the formula 1 of the present invention, ie, represented by the formulas 8a and 8b and the formulas 9a and 9b. The production of the compound according to the reaction scheme (I)
And can be performed as follows.

【0016】式1cで表される化合物をエーテル、t−
ブチルメチルエーテル、1,2ジメトキシエタン、テト
ラヒドロフラン、ジオキサン等の溶媒中で過剰量(約5
等量)のナトリウムビス(メトキシエトキシ)アルミニ
ウムハイドリドで還元すると2位のアセチレンが部分還
元され、S−E−8−トリメチルシリル−5−t−ブチ
ルジメチルシロキシ−オクタ−2−エン−7−イン−1
−オール(4a)とS−E−5−t−ブチルジメチルシ
ロキシ−オクタ−2−エン−7−イン−1−オール(4
b)が各々65%,32%の収率で得られる。これらは容易
に分離することができるが、混合物のまま用いることも
できる。また、式1dの化合物を同様に部分還元しても
収率27%と低いが式4bの化合物のみを得ることができ
る。なお,式4aの化合物も同様にC1 〜C4 アルコー
ル等の溶媒中で炭酸ナトリウム、炭酸カリウム等の塩基
と加熱することによりトリメチルシリル基を脱離させて
ほぼ定量的に式4bの化合物に変換することができる。
The compound represented by the formula 1c is converted to an ether, t-
In a solvent such as butyl methyl ether, 1,2 dimethoxyethane, tetrahydrofuran, dioxane, etc.
Reduction with sodium bis (methoxyethoxy) aluminum hydride, the acetylene at the 2-position is partially reduced to give SE-8-trimethylsilyl-5-t-butyldimethylsiloxy-oct-2-en-7-yne. -1
-Ol (4a) and SE-5-tert-butyldimethylsiloxy-oct-2-en-7-yn-1-ol (4
b) is obtained in 65% and 32% yield, respectively. These can be easily separated, but can also be used as a mixture. Similarly, when the compound of the formula 1d is similarly partially reduced, only the compound of the formula 4b can be obtained although the yield is as low as 27%. Similarly, the compound of formula 4a is almost quantitatively converted to the compound of formula 4b by heating the compound of formula 4a with a base such as sodium carbonate or potassium carbonate in a solvent such as C 1 -C 4 alcohol to remove the trimethylsilyl group. can do.

【0017】式4aの化合物をジクロロメタン、クロロ
ホルム、四塩化炭素、1,2−ジクロロエタン等の溶媒
中、m−クロロ過安息香酸で酸化すると小量のα−エポ
キシドとともに式6aで表される望ましい配置をもつβ
−エポキシド化合物が収率73%で得られる。式6aの化
合物は香月-Sharpless不斉エポキシ化の条件、即ちL−
酒石酸ジイソプロピル存在下で式4aの化合物をエポキ
シ化するとほぼ定量的にえられる。式4bの化合物から
も同様にm−クロロ過安息香酸で酸化して式6aと同じ
配置を持つβ−エポキシド化合物6cが収率74%で得ら
れる。
Oxidation of the compound of formula 4a with m-chloroperbenzoic acid in a solvent such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, etc. together with a small amount of α-epoxide provides the desired configuration of formula 6a. Β with
An epoxide compound is obtained with a yield of 73%. The compound of formula 6a is subjected to the conditions of Katsuki-Sharpless asymmetric epoxidation, ie, L-
Epoxidation of the compound of formula 4a in the presence of diisopropyl tartrate can be obtained almost quantitatively. The compound of formula 4b is similarly oxidized with m-chloroperbenzoic acid to give a β-epoxide compound 6c having the same configuration as that of formula 6a in a yield of 74%.

【0018】次に式6a及び6cの化合物をトリフェニ
ルホスフィン、イミダゾール存在下でヨウ素と反応させ
るとそれぞれ式6b及び6dのヨウ素化合物が得られ
る。式6bのヨウ化物を酢酸を含むC1 〜C4 アルコー
ル等の溶媒中で活性化させた亜鉛末と反応させると式7
aの化合物5R,3R−8−トリメチルシリル−5−t
−ブチルジメチルシリル−3−ヒドロキシ−オクタ−7
−イン−1−エンが収率85%で得られる。式7aの化合
物をC1 〜C4 アルコール等の溶媒中で炭酸ナトリウ
ム、炭酸カリウム等の塩基と加熱すると8位のシリル基
が脱離した式7bの化合物がほぼ定量的に得られる。ま
た式7bの化合物は式6dの化合物を酢酸を含むメタノ
ール中で活性化された亜鉛と反応させることによっても
得られる。これをジメチルホルムアミド中、イミダゾー
ル、ジメチルアミノピリジン共存下にt−ブチルジメチ
ルシリルクロリドでシリル化して式7cの化合物とし、
メチルリチウム、n−ブチルリチウム、 sec−ブチルリ
チウム、t−ブチルリチウム等のC1 〜C4 のアルキル
リチウムでリチウムアセチリドとした後、クロロ炭酸メ
チルあるいはクロロ炭酸メチルと反応させると目的とす
るカルシトリオール及びその関連の重要中間体の一つで
ある式8a,8bの鎖状化合物が得られる。式8a,8
bの化合物をトリス(ジベンジリデンアセトン)ジパラ
ジウム・クロロフォルム錯体を触媒として環化反応を行
うと目的とするカルシトリオール及びその関連化合物の
もう一つの重要中間体、式9a,9bで表されるジアル
キリデンシクロヘキサン誘導体が得られる。
Next, the compounds of formulas 6a and 6c are reacted with iodine in the presence of triphenylphosphine and imidazole to obtain the iodine compounds of formulas 6b and 6d, respectively. Reaction of iodide of formula 6b with C 1 -C 4 zinc dust activated with a solvent such as an alcohol containing acetic acid Formula 7
Compound 5R, 3R-8-trimethylsilyl-5-t of a
-Butyldimethylsilyl-3-hydroxy-oct-7
-In-1-ene is obtained in a yield of 85%. When the compound of the formula 7a is heated with a base such as sodium carbonate or potassium carbonate in a solvent such as a C 1 -C 4 alcohol, the compound of the formula 7b from which the silyl group at the 8-position is eliminated can be obtained almost quantitatively. The compound of formula 7b can also be obtained by reacting the compound of formula 6d with activated zinc in methanol containing acetic acid. This was silylated with t-butyldimethylsilyl chloride in dimethylformamide in the presence of imidazole and dimethylaminopyridine to give a compound of formula 7c,
Methyl lithium, n- butyl lithium, sec- butyl lithium, t-after with lithium acetylide with an alkyl lithium C 1 -C 4 such as butyl lithium, calcitriol which is reacted with methyl chlorocarbonate or methyl chlorocarbonate intended And one of the related key intermediates, the chain compounds of formulas 8a and 8b. Equations 8a and 8
When the compound b is subjected to a cyclization reaction using a tris (dibenzylideneacetone) dipalladium-chloroform complex as a catalyst, another important intermediate of the desired calcitriol and its related compounds, a dimer represented by the formulas 9a and 9b, An alkylidenecyclohexane derivative is obtained.

【0019】[0019]

【実施例】【Example】

実施例1 <式1aの化合物の合成>トリメチルシリルアセチレン
( 6.8g,69.4mM)のテトラヒドロフラン( 110ml)溶液
に−78℃で 1.56M n−ブチルリチウムのn−ヘキサン
溶液( 37ml,57.8mM)を徐々に滴下し、同温度で 1.5時
間攪拌し、さらにトリフルオロボロン・エーテル錯体
(7.2ml,57.8mM)を徐々に滴下し、同温度で 0.5時間攪
拌した。この反応液に式3の化合物( 7.6g,38.6mM)の
テトラヒドロフラン(10ml)溶液を−78℃で徐々に滴下
し、同温度で 2.5時間攪拌した後、室温まで徐々に昇温
した。この反応液に水(20ml)を加え、エーテル 300ml
で2回抽出した。合わせた有機層を硫酸マグネシウムで
乾燥し、減圧下に溶媒を留去した。残渣をシリカゲルカ
ラムクロマトグラフィーに付し、エーテル/n−ヘキサ
ン( 1:3 )の留分から無色の式1aの化合物8.8gを得
た。収率は78%、ただし原料の回収を考慮すると収率は
82%であった。
Example 1 <Synthesis of Compound of Formula 1a> To a solution of trimethylsilylacetylene (6.8 g, 69.4 mM) in tetrahydrofuran (110 ml) was slowly added a 1.56 M n-butyllithium n-hexane solution (37 ml, 57.8 mM) at −78 ° C. And stirred at the same temperature for 1.5 hours. Further, a trifluoroboron ether complex (7.2 ml, 57.8 mM) was gradually added dropwise, and the mixture was stirred at the same temperature for 0.5 hour. A solution of the compound of formula 3 (7.6 g, 38.6 mM) in tetrahydrofuran (10 ml) was gradually added dropwise to the reaction solution at -78 ° C, and the mixture was stirred at the same temperature for 2.5 hours and then gradually heated to room temperature. Water (20 ml) was added to the reaction solution, and ether (300 ml) was added.
And extracted twice. The combined organic layer was dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 8.8 g of a colorless compound of the formula 1a from a fraction of ether / n-hexane (1: 3). The yield is 78%, but considering the recovery of raw materials, the yield is
82%.

【0020】また式1aの化合物は次の方法でも合成で
きた。即ち、プロパルギルテトラヒドロピラニルエーテ
ル(2.0g,13.64mM)のテトラヒドロフラン(20ml)溶液
に−78℃で1.4M n−ブチルリチウムのn−ヘキサン溶
液( 7.8ml,10.91mM)を徐々に滴下し、同温度で 0.5時
間攪拌し、さらにトリフルオロボロン・エーテル錯体
( 1.3ml,10.91mM)を徐々に滴下し、同温度で 0.5時間
攪拌した。この反応液に式 2の化合物( 1.4g,9.09mM)
のテトラヒドロフラン( 5ml)溶液を−78℃で徐々に滴
下し、同温度で 2.5時間攪拌した後、室温まで徐々に昇
温した。この反応液に水(20ml)を加え、エーテル 250
mlで2回抽出した。合わせた有機層を硫酸マグネシウム
で乾燥し、減圧下に溶媒を留去した。残渣をシリカゲル
カラムクロマトグラフィーに付し、エーテル/n−ヘキ
サン( 1:3 )の留分から無色の式1の化合物 1.79gを
得た。収率は67%であった。この方法で得た式1aの化
合物のスペクトルデータは先の方法で得た化合物と一致
した。式1aの化合物のスペクトルデータおよび元素分
析結果は以下の通りである。
The compound of the formula 1a could also be synthesized by the following method. That is, to a solution of propargyl tetrahydropyranyl ether (2.0 g, 13.64 mM) in tetrahydrofuran (20 ml) was slowly added dropwise a solution of 1.4 M n-butyllithium in n-hexane (7.8 ml, 10.91 mM) at −78 ° C. For 0.5 hour, trifluoroboron ether complex (1.3 ml, 10.91 mM) was gradually added dropwise, and the mixture was stirred at the same temperature for 0.5 hour. The compound of formula 2 (1.4 g, 9.09 mM) was added to the reaction mixture.
Of tetrahydrofuran (5 ml) was slowly added dropwise at -78 ° C, and the mixture was stirred at the same temperature for 2.5 hours, and then gradually heated to room temperature. Water (20 ml) was added to the reaction solution, and ether 250
Extracted twice with ml. The combined organic layer was dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 1.79 g of a colorless compound of the formula 1 from a fraction of ether / n-hexane (1: 3). The yield was 67%. The spectral data of the compound of formula 1a obtained by this method was consistent with the compound obtained by the previous method. The spectrum data and elemental analysis result of the compound of the formula 1a are as follows.

【0021】IRνmax (neat)cm-1 ; 3438 , 2954 , 2
872 , 2174 , 1249 , 1025 , 841。1 H−NMR (300MHz , CDCl3); δ4.77(t, 1H, J=2.9H
z), 4.28( dt, 1H, J=15.4, 2.2Hz),4.19( dt, 1
H, J=1.8, 15.8Hz), 3.94〜3.76( m,2H), 3.57〜3.
45( m,1H), 2.50(d, 1H, J=6.2Hz), 2.62〜2.38
( m,4H), 2.87〜2.44( m,6H), 0.13( s, 9H)。 MS ; 293(M+ −H+ ), 85( 100%)。 Anal. Calcd. for C16H26O3Si, C;65.27, H;8.91。 Found: C;65.01, H;8.85。
IRνmax (neat) cm -1 ; 3438, 2954, 2
872, 2174, 1249, 1025, 841. 1 H-NMR (300 MHz, CDCl 3 ); δ 4.77 (t, 1 H, J = 2.9 H
z), 4.28 (dt, 1H, J = 15.4, 2.2Hz), 4.19 (dt, 1
H, J = 1.8, 15.8Hz), 3.94-3.76 (m, 2H), 3.57-3.
45 (m, 1H), 2.50 (d, 1H, J = 6.2Hz), 2.62 to 2.38
(M, 4H), 2.87 to 2.44 (m, 6H), 0.13 (s, 9H). MS; 293 (M < + >- H < + > ), 85 (100%). Anal. Calcd. For C 16 H 26 O 3 Si, C; 65.27, H; 8.91. Found: C; 65.01, H; 8.85.

【0022】実施例2 <式1bの化合物の合成>式1aの化合物( 2.1g,7.11
mM)のジメチルホルムアミド(18ml)溶液に室温でイミ
ダゾール(1.8ml,27.0mM)とt−ブチルジメチルシリル
クロリド(1.7mg,11.4mM)を加えて6時間攪拌した。こ
の反応液に水(10ml)を加え、エーテル 200mlで2回抽
出した。合わせた有機層を硫酸マグネシウムで乾燥し、
減圧下に溶媒を留去した。残渣をシリカゲルカラムクロ
マトグラフィーに付し、エーテル/n−ヘキサン( 1:
20)の留分から無色油状の式1bの化合物2.9gを得た。
収率はほぼ定量的であった。式1bの化合物のスペクト
ルデータおよび元素分析結果は以下の通りである。
Example 2 <Synthesis of Compound of Formula 1b> Compound of Formula 1a (2.1 g, 7.11)
Immidazole (1.8 ml, 27.0 mM) and t-butyldimethylsilyl chloride (1.7 mg, 11.4 mM) were added to a dimethylformamide (18 mM) solution at room temperature and stirred for 6 hours. Water (10 ml) was added to the reaction solution, and the mixture was extracted twice with 200 ml of ether. The combined organic layers are dried over magnesium sulfate,
The solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and ether / n-hexane (1: 1:
From the fraction of 20), 2.9 g of the compound of the formula 1b was obtained as a colorless oil.
The yield was almost quantitative. The spectrum data and elemental analysis result of the compound of the formula 1b are as follows.

【0023】IRνmax (neat)cm-1; 2954 , 2856 , 21
76 , 1250 , 1107 , 1025 , 840 。1 H−NMR (300MHz , CDCl3); δ4.79(t, 1H, J=2.9H
z), 4.28( dt, 1H, J=15.4, 2.2Hz),4.18( dt, 1
H, J=2.2, 15.8Hz), 4.00〜3.78( m, 2H), 3.58〜3.
47( m, 1H), 2.53( dd, 1H, J=5.5, 16.9Hz), 2.39
( dd, 1H, J=6.2, 16.8Hz),2.59〜2.34( m, 2H),
1.89〜1.46( m, 6H), 0.89( s, 9H),0.14( s, 9
H), 0.11( s, 3H), 0.10( s, 3H)。 MS ; 351(M+ −t−Bu), 107( 100%), 85( 100
%)。 Anal. Calcd. for C18H31O3Si2 , C;64.67, H;9.8
7。 Found: C;64.41, H;9.96。
IRνmax (neat) cm -1 ; 2954, 2856, 21
76, 1250, 1107, 1025, 840. 1 H-NMR (300 MHz, CDCl 3 ); δ 4.79 (t, 1 H, J = 2.9 H
z), 4.28 (dt, 1H, J = 15.4, 2.2Hz), 4.18 (dt, 1
H, J = 2.2, 15.8Hz), 4.00-3.78 (m, 2H), 3.58-3.
47 (m, 1H), 2.53 (dd, 1H, J = 5.5, 16.9Hz), 2.39
(Dd, 1H, J = 6.2, 16.8Hz), 2.59 ~ 2.34 (m, 2H),
1.89 to 1.46 (m, 6H), 0.89 (s, 9H), 0.14 (s, 9
H), 0.11 (s, 3H), 0.10 (s, 3H). MS; 351 (M + -t-Bu), 107 (100%), 85 (100
%). Anal. Calcd. For C 18 H 31 O 3 Si 2 , C; 64.67, H; 9.8
7. Found: C; 64.41, H; 9.96.

【0024】実施例3 <式1cの化合物の合成>式1bの化合物(44.2mg, 0.
11mM)のメタノール( 1ml)溶液にピリジニウムp−ト
ルエンスルフォナート(10mg, 0.04mM)を加え、室温で
17時間攪拌した。この反応液の溶媒を減圧下に留去し、
飽和食塩水( 5ml)を加え、エーテル30mlで2回抽出し
た。合わせた有機層を硫酸マグネシウムで乾燥し、減圧
下に溶媒を留去した。残渣をシリカゲルカラムクロマト
グラフィーに付し、エーテル/n−ヘキサン(1:10)
の留分から無色油状の式1cの化合物28.4mgを得た。収
率は81%、ただし原料の回収を考慮すると収率は88%で
あった。式1cの化合物のスペクトルデータおよび元素
分析結果は以下の通りである。
Example 3 <Synthesis of Compound of Formula 1c> Compound of formula 1b (44.2 mg, 0.2
Pyridinium p-toluenesulfonate (10 mg, 0.04 mM) was added to a solution of 11 mM) in methanol (1 ml), and the solution was added at room temperature.
Stir for 17 hours. The solvent of this reaction solution was distilled off under reduced pressure,
Saturated saline (5 ml) was added, and the mixture was extracted twice with 30 ml of ether. The combined organic layer was dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and ether / n-hexane (1:10).
28.4 mg of the compound of the formula 1c was obtained as a colorless oil from the fraction. The yield was 81%, however, considering the recovery of the raw materials, the yield was 88%. The spectrum data and elemental analysis result of the compound of the formula 1c are as follows.

【0025】 [α]D 30; + 9.0°(C =1.01, メタノール)。 IRνmax (neat)cm-1 ; 3362 , 2956 , 2930 , 2856 ,
2176 , 1250 , 1103, 8401 H−NMR (300MHz , CDCl3); δ4.31〜4.21( m, 2
H), 3.93(quint, 1H, J=5.9Hz), 2.53( dd, 1H, J=
16.5, 5.5Hz), 2.40( dd, 1H, J=6.2, 16.8Hz),2.6
0〜2.34( m, 2H), 1.50(dd, 1H, J=6.2, 5.9Hz),
0.90( s, 9H), 0.15( s, 9H), 0.13( s, 6H)。 MS ; 324(M+ ), 267(M+ −57), 73( 100%)。 Anal. Calcd. for C17H32O1Si2 , C ; 62.90, H ; 9.9
4 。 Found: C ; 62.51, H ; 10.03 。
[Α] D 30 ; + 9.0 ° (C = 1.01, methanol). IRνmax (neat) cm -1 ; 3362, 2956, 2930, 2856,
2176, 1250, 1103, 840 1 H-NMR (300 MHz, CDCl 3 ); δ 4.31 to 4.21 (m, 2
H), 3.93 (quint, 1H, J = 5.9Hz), 2.53 (dd, 1H, J =
16.5, 5.5Hz), 2.40 (dd, 1H, J = 6.2, 16.8Hz), 2.6
0 ~ 2.34 (m, 2H), 1.50 (dd, 1H, J = 6.2, 5.9Hz),
0.90 (s, 9H), 0.15 (s, 9H), 0.13 (s, 6H). MS; 324 (M + ), 267 (M + -57), 73 (100%). .. Anal Calcd for C 17 H 32 O 1 Si 2, C; 62.90, H; 9.9
Four . Found: C; 62.51, H; 10.03.

【0026】実施例4 <式1dの化合物の合成>式1cの化合物( 1.38g, 4.
26mM)のメタノール(50ml)溶液に炭酸カリウム(1.47
g, 10.65mM)を室温で加え、40℃に昇温して 0.5時間攪
拌した。この反応液の溶媒を減圧下に留去し、飽和食塩
水( 5ml)を加え、エーテル30mlで2回抽出した。合わ
せた有機層を硫酸マグネシウムで乾燥し、減圧下に溶媒
を留去した。残渣をシリカゲルカラムクロマトグラフィ
ーに付し、エーテル/n−ヘキサン(1:2)の留分か
ら無色油状の式1dの化合物 1.04gを得た。収率は97%
であった。式1dの化合物のスペクトルデータおよび元
素分析結果は以下の通りである。
Example 4 <Synthesis of Compound of Formula 1d> Compound of formula 1c (1.38 g, 4.
26mM) in methanol (50ml) and potassium carbonate (1.47)
g, 10.65 mM) at room temperature, and the mixture was heated to 40 ° C. and stirred for 0.5 hour. The solvent of this reaction solution was distilled off under reduced pressure, saturated saline (5 ml) was added, and the mixture was extracted twice with 30 ml of ether. The combined organic layer was dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 1.04 g of a compound of the formula 1d as a colorless oil from a fraction of ether / n-hexane (1: 2). 97% yield
Met. The spectrum data and elemental analysis result of the compound of the formula 1d are as follows.

【0027】 [α]D 26;− 1.6°(C=0.86, メタノール)。 IRνmax (neat)cm-1 ; 3310 , 2930 , 2856 , 2228 ,
2120 , 1256 , 1110。1 H−NMR (300MHz , CDCl3 ;δ4.25(dt, 2H, J=5.9,
1.8Hz), 3.94(quint,1H, J=5.9Hz), 2.58〜2.35(
m, 4H), 2.00(t, 1H, J=2.6Hz), 1.58(t, 1H, J=5.
9Hz), 0.90( s, 9H), 0.11( s, 6H)。 MS ; 251(M+ −H+ ), 235 (M+ −OH), 213(M
+ −HC=CCH)75( 100%)。 Anal. Calcd. for C14H24O2Si , C ; 66.61, H ; 9.5
8。 Found: C ; 66.53, H ; 9.66。
[Α] D 26 ; -1.6 ° (C = 0.86, methanol). IRνmax (neat) cm -1 ; 3310, 2930, 2856, 2228,
2120, 1256, 1110. 1 H-NMR (300 MHz, CDCl 3 ; δ 4.25 (dt, 2H, J = 5.9,
1.8Hz), 3.94 (quint, 1H, J = 5.9Hz), 2.58-2.35 (
m, 4H), 2.00 (t, 1H, J = 2.6Hz), 1.58 (t, 1H, J = 5.
9Hz), 0.90 (s, 9H), 0.11 (s, 6H). MS; 251 (M + -H + ), 235 (M + -OH), 213 (M
+ -HC = CCH) 75 (100%). Anal.Calcd. For C 14 H 24 O 2 Si, C; 66.61, H; 9.5
8. Found: C; 66.53, H; 9.66.

【0028】実施例5 <式4aの化合物の合成>式1cの化合物( 2.35g, 7.
25mM)のエーテル(50ml)溶液に35%ナトリウムビス
(2−メトキシエトキシ)アルミニウムハイドライド/
トルエン溶液(21ml, 34.8mM)を 0℃で加え、徐々に室
温まで昇温して 1時間攪拌した。この反応液に10%NaOH
水溶液( 7ml)を加えて20分間攪拌し、ジクロロメタン
300mlで2回抽出した。合わせた有機層を飽和食塩水30
mlで洗浄後、硫酸マグネシウムで乾燥し、減圧下に溶媒
を留去した。残渣をシリカゲルカラムクロマトグラフィ
ーに付し、エーテル/n−ヘキサン(1:2)の留分か
ら無色油状の式4aの化合物 1.51g(64%)と、同じく
無色油状の式4bの化合物 573mg(31%)を得た。原料
回収は44mg(2%)であった。式4aの化合物のスペク
トルデータおよび元素分析結果は以下の通りである。
Example 5 <Synthesis of compound of formula 4a> Compound of formula 1c (2.35 g, 7.
25mM) in ether (50ml) solution with 35% sodium bis (2-methoxyethoxy) aluminum hydride /
A toluene solution (21 ml, 34.8 mM) was added at 0 ° C., and the temperature was gradually raised to room temperature, followed by stirring for 1 hour. Add 10% NaOH to the reaction
Add an aqueous solution (7 ml), stir for 20 minutes, and add dichloromethane
Extracted twice with 300 ml. The combined organic layer was washed with saturated saline 30
After washing with ml, the solution was dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and from a fraction of ether / n-hexane (1: 2), 1.51 g (64%) of a colorless oily compound of the formula 4a and 573 mg (31%) of a colorless oily compound of the formula 4b ) Got. Raw material recovery was 44 mg (2%). The spectrum data and elemental analysis result of the compound of the formula 4a are as follows.

【0029】 [α]D 28;+ 3.9°(C=0.92, メタノール)。 IRνmax (neat)cm-1 ; 3344 , 2956 , 2930 , 2898 ,
2858 , 2176 , 1250, 1101 , 840 , 773。1 H−NMR (500MHz , CDCl3); δ5.72〜5.64( m, 2H)
4.13〜4.04( m, 2H)3.83( ddd, 1H, J=5.5, 6.1, 1
1.6Hz), 2.32(d, 2H, J=6.1Hz),2.36〜2.21( m, 2
H), 1.24(dd, 1H, J=5.5, 6.1Hz), 0.87( s, 9H),
0.12( s, 9H), 0.08( s, 3H), 0.04( s, 3H)。 MS ; 325(M+ −H+ ), 269(M+ −57), 73( 100
%)。 Anal. Calcd. for C14H24O2Si , C ; 62.51, H ; 10.4
9 。 Found:C ; 62.44, H ; 10.42。
[Α] D 28 ; + 3.9 ° (C = 0.92, methanol). IRνmax (neat) cm -1 ; 3344, 2956, 2930, 2898,
2858, 2176, 1250, 1101, 840, 773. 1 H-NMR (500 MHz, CDCl 3 ); δ 5.72 to 5.64 (m, 2H)
4.13 to 4.04 (m, 2H) 3.83 (ddd, 1H, J = 5.5, 6.1, 1
1.6Hz), 2.32 (d, 2H, J = 6.1Hz), 2.36 to 2.21 (m, 2
H), 1.24 (dd, 1H, J = 5.5, 6.1Hz), 0.87 (s, 9H),
0.12 (s, 9H), 0.08 (s, 3H), 0.04 (s, 3H). MS; 325 (M + -H + ), 269 (M + -57), 73 (100
%). Anal.Calcd. For C 14 H 24 O 2 Si, C; 62.51, H; 10.4
9. Found: C; 62.44, H; 10.42.

【0030】実施例6 <式4bの化合物の合成>式1dの化合物( 692mg, 2.
75mM)のエーテル(12.5ml)溶液に35%ナトリウムビス
(2−メトキシエトキシ)アルミニウムハイドライド/
トルエン溶液( 7.6ml, 13.2mM)を0℃で加え、 1時間
20分攪拌後、室温まで昇温して6時間攪拌した。この反
応液に10%NaOH水溶液(4ml)を加えて20分間攪拌し、
ジクロロメタン 150mlで 2回抽出した。合わせた有機層
を飽和食塩水15mlで洗浄後、硫酸マグネシウムで乾燥
し、減圧下に溶媒を留去した。残渣をシリカゲルカラム
クロマトグラフィーに付し、エーテル/n−ヘキサン
(1:2)の留分から無色油状の式4bの化合物 188mg
を得た。収率は27%であった。式4bの化合物のスペク
トルデータおよび元素分析結果は以下の通りである。
Example 6 <Synthesis of Compound of Formula 4b> Compound of formula 1d (692 mg, 2.
75mM) in ether (12.5ml) in 35% sodium bis (2-methoxyethoxy) aluminum hydride /
Toluene solution (7.6ml, 13.2mM) was added at 0 ° C and 1 hour
After stirring for 20 minutes, the mixture was heated to room temperature and stirred for 6 hours. A 10% aqueous NaOH solution (4 ml) was added to the reaction solution, and the mixture was stirred for 20 minutes.
Extracted twice with 150 ml of dichloromethane. The combined organic layer was washed with 15 ml of saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and 188 mg of the compound of the formula 4b was obtained as a colorless oil from a fraction of ether / n-hexane (1: 2).
I got The yield was 27%. The spectrum data and elemental analysis result of the compound of the formula 4b are as follows.

【0031】 [α]D 25;− 6.0°(C=0.86, クロロフォルム) IRνmax (neat)cm-1 ; 3312, 2952 , 2932 , 2856 ,
2120 , 1100 , 835 。1 H− NMR(300MHz , CDCl3);δ5.73〜5.70( m, 2H)
4.13〜4.10( m, 2H)3.86(quint, 1H, J=5.9Hz), 2.
32(dd, 2H, J=2.6, 6.2Hz), 2.44〜2.25( m, 2H),
1.99(t, 1H, J=2.6Hz), 1.26(t, 1H, J=5.9Hz), 0.
89( s, 9H),0.08( s, 3H), 0.06( s, 3H)。 MS ; 237(M+ −OH), 215 (M+ −CH2C≡CH), 143
(M+ −111 ),75( 100%)。 Anal. Calcd. for C14H26O2Si , C ; 66.09, H ; 10.3
0 。 Found: C ; 66.04 , H ; 10.10。
[Α] D 25 ; −6.0 ° (C = 0.86, chloroform) IRνmax (neat) cm −1 ; 3312, 2952, 2932, 2856,
2120, 1100, 835. 1 H-NMR (300 MHz, CDCl 3 ); δ 5.73 to 5.70 (m, 2H)
4.13 to 4.10 (m, 2H) 3.86 (quint, 1H, J = 5.9Hz), 2.
32 (dd, 2H, J = 2.6, 6.2Hz), 2.44 to 2.25 (m, 2H),
1.99 (t, 1H, J = 2.6Hz), 1.26 (t, 1H, J = 5.9Hz), 0.
89 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H). MS; 237 (M + -OH), 215 (M + -CH 2 C≡CH), 143
(M + -111), 75 (100%). Anal.Calcd. For C14H26O2Si, C; 66.09, H; 10.3
0. Found: C; 66.04, H; 10.10.

【0032】実施例7 <式6aの化合物の合成>式4aの化合物( 240mg, 0.
74mM)のジクロロメタン(24ml)溶液に炭酸水素ナトリ
ウム( 185mg, 2.21mM)とm−クロロ過安息香酸( 270
mg, 1.10mM)を0℃で加え、同温度で2時間攪拌した。
この反応液に0℃で飽和亜硫酸水素ナトリウム水溶液
(20ml)を加えて、20分攪拌後、室温まで昇温し、ジク
ロロメタン 120mlで2回抽出した。合わせた有機層を飽
和炭酸水素ナトリウム水溶液(20ml)、ついで飽和食塩
水(20ml)で洗浄後、硫酸マグネシウムで乾燥し、減圧
下に溶媒を留去した。残渣をシリカゲルカラムクロマト
グラフィーに付し、エーテル/n−ヘキサン(1:3)
の留分から無色油状の式6aで表されるβ−エポキシド
とその異性体であるα−エポキシドを各々 183.5mg(収
率73%), 18.4mg(収率7.3%)得た。式6aの化合物
のスペクトルデータおよび元素分析結果は以下の通りで
ある。
Example 7 <Synthesis of Compound of Formula 6a> A compound of Formula 4a (240 mg, 0.2 g
Sodium bicarbonate (185 mg, 2.21 mM) and m-chloroperbenzoic acid (270
mg, 1.10 mM) at 0 ° C. and stirred at the same temperature for 2 hours.
To this reaction solution was added a saturated aqueous solution of sodium hydrogen sulfite (20 ml) at 0 ° C., and the mixture was stirred for 20 minutes, heated to room temperature, and extracted twice with 120 ml of dichloromethane. The combined organic layer was washed with a saturated aqueous solution of sodium hydrogen carbonate (20 ml) and then with a saturated saline solution (20 ml), dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and ether / n-hexane (1: 3)
From the fractions, 183.5 mg (yield 73%) and 18.4 mg (7.3% yield) of a colorless oily β-epoxide represented by the formula 6a and its isomer α-epoxide were obtained, respectively. The spectrum data and elemental analysis result of the compound of the formula 6a are as follows.

【0033】 [α]D 32;−43.3°(C=1.28, クロロフォルム) IRνmax (neat)cm-1; 3446, 2954 , 2856 , 2176 , 1
744 , 1731 , 663。1 H−NMR (500MHz , CDCl3); δ4.01〜3.97( m, 1H)
3.91( ddd, 1H, J=3.1, 5.5, 12.8Hz), 3.61(ddd, 1
H, J=4.3, 7.3, 12.2 Hz),3.09〜3.05( m,1H), 2.4
1〜2.36( m, 2H),1.83〜1.73( m, 2H),1.70(dd,
1H, J=5.5, 7.3Hz), 0.87( s, 9H), 0.11( s, 9
H), 0.09( s, 6H)。 MS ; 285(M+ −57), 267 (M+ −75), 145(M+
−197 ),73( 100%)。 Anal. Calcd. for C17H34O3Si2 , C ; 59.61 , H ; 1
0.01 。 Found: C ; 59.42 , H ; 9.99 。
[Α] D 32 ; -43.3 ° (C = 1.28, chloroform) IRνmax (neat) cm −1 ; 3446, 2954, 2856, 2176, 1
744, 1731, 663. 1 H-NMR (500 MHz, CDCl 3 ); δ 4.01 to 3.97 (m, 1H)
3.91 (ddd, 1H, J = 3.1, 5.5, 12.8Hz), 3.61 (ddd, 1
H, J = 4.3, 7.3, 12.2 Hz), 3.09 to 3.05 (m, 1H), 2.4
1 to 2.36 (m, 2H), 1.83 to 1.73 (m, 2H), 1.70 (dd,
1H, J = 5.5, 7.3Hz), 0.87 (s, 9H), 0.11 (s, 9
H), 0.09 (s, 6H). MS; 285 (M + -57), 267 (M + -75), 145 (M +
−197), 73 (100%). Anal.Calcd. For C 17 H 34 O 3 Si 2 , C; 59.61, H; 1
0.01. Found: C; 59.42, H; 9.99.

【0034】実施例8 <式6cの化合物の合成>式4bの化合物( 1.23g, 4.
86mM)のジクロロメタン(80ml)溶液に炭酸水素ナトリ
ウム(1.22g, 14.57mM)とm−クロロ過安息香酸( 1.2
6g, 7.29mM)を0℃で加え、同温度で2時間攪拌した。
この反応液に0℃で飽和亜硫酸水素ナトリウム水溶液
(60ml)を加えて、20分攪拌後、室温まで昇温し、ジク
ロロメタン 400mlで2階抽出した。合わせた有機層を飽
和炭酸水素ナトウリム水溶液(60ml)、ついで飽和食塩
水(60ml)で洗浄後、硫酸マグネシウムで乾燥し、減圧
下に溶媒を留去した。残渣をシリカゲルカラムクロマト
グラフィーに付し、エーテル/n−ヘキサン(1:1)
の留分から無色油状の式6cで表されるβ−エポキシド
とその異性体であるα−エポキシドを各々 969.2mg(収
率74%), 80.8mg(収率6.2%)得た。式6cの化合物
のスペクトルデータおよび元素分析結果は以下の通りで
ある。
Example 8 <Synthesis of Compound of Formula 6c> Compound of formula 4b (1.23 g, 4.
86 mM) in dichloromethane (80 ml) solution and sodium hydrogencarbonate (1.22 g, 14.57 mM) and m-chloroperbenzoic acid (1.2
6 g, 7.29 mM) at 0 ° C., and the mixture was stirred at the same temperature for 2 hours.
To this reaction solution was added a saturated aqueous solution of sodium hydrogen sulfite (60 ml) at 0 ° C., and the mixture was stirred for 20 minutes. The combined organic layer was washed with a saturated aqueous sodium hydrogen carbonate solution (60 ml) and then with a saturated saline solution (60 ml), dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and ether / n-hexane (1: 1).
From the above fraction, 969.2 mg (yield 74%) and 80.8 mg (6.2% yield) of a colorless oily β-epoxide represented by the formula 6c and its isomer α-epoxide were obtained. The spectrum data and elemental analysis result of the compound of the formula 6c are as follows.

【0035】 [α]D 27;−51.4°(C=1.04, クロロフォルム) IRνmax (neat)cm-1 ; 3422, 3310 , 2934 , 2856 ,
2120 , 1256 , 1102。1 H−NMR (300MHz , CDCl3); δ4.07〜3.99( m, 1H)
3.93( ddd, 1H, J=2.6, 5.5, 12.5Hz), 3.64( ddd,
1H, J=4.0, 7.3, 11.7Hz), 3.11(ddd, 1H, J=2.2, 4.
8, 7.0Hz), 3.00〜2.94( m, 1H), 2.40〜2.36( m,
2H), 2.00(t,1H, J=2.6Hz), 1.91〜1.74( m, 2
H),1.66(dd, 1H, J=5.5, 7.0Hz), 0.90( s, 9H),
0.11( s, 3H), 0.10( s, 3H)。 MS ; 231(M+ −39), 213 (M+ −57), 145 (M+
−125 ),75( 100%)。 HRMS Calcd. for C11H23O3Si (−CH2C=CH ), 231.
1416。 Found: 231.1429 。
[Α] D 27 ; −51.4 ° (C = 1.04, chloroform) IRνmax (neat) cm −1 ; 3422, 3310, 2934, 2856,
2120, 1256, 1102. 1 H-NMR (300 MHz, CDCl 3 ); δ 4.07 to 3.99 (m, 1H)
3.93 (ddd, 1H, J = 2.6, 5.5, 12.5Hz), 3.64 (ddd,
1H, J = 4.0, 7.3, 11.7Hz), 3.11 (ddd, 1H, J = 2.2, 4.
8, 7.0Hz), 3.00 to 2.94 (m, 1H), 2.40 to 2.36 (m,
2H), 2.00 (t, 1H, J = 2.6Hz), 1.91 to 1.74 (m, 2
H), 1.66 (dd, 1H, J = 5.5, 7.0Hz), 0.90 (s, 9H),
0.11 (s, 3H), 0.10 (s, 3H). MS; 231 (M + -39), 213 (M + -57), 145 (M +
−125), 75 (100%). HRMS Calcd. For C11H23O3Si (-CH 2 C = CH), 231.
1416. Found: 231.1429.

【0036】実施例9 <式6bの化合物の合成>式6aの化合物( 430mg, 1.
26mM)を 4 : 1−テトラヒドロフラン/アセトニトリル
(24ml; 6ml)混合溶媒に溶かし、トリフェニルホスフ
ィン( 990mg, 3.77mM), イミダゾール( 642mg, 9.43
mM), ヨウ素( 960mg, 7.54mM)を順次加え、室温で30
分間攪拌した。この反応液に飽和炭酸水素ナトリウム水
溶液(10ml)を加え、エーテル 120mlで2回抽出した。
合わせた有機層を10%亜硫酸ナトリウム水溶液10ml,飽
和炭酸水素ナトリウム水溶液10ml、飽和食塩水10mlで順
次洗浄後、硫酸マグネシウムで乾燥し、減圧下に溶媒を
留去した。残渣をシリカゲルカラムクロマトグラフィー
に付し、エーテル/n−ヘキサン(1:20)の留分から
無色油状の式6bで表されるβ−エポキシアイオダイド
486.3mg(収率85%)を得た。式6bの化合物のスペク
トルデータおよび元素分析結果は以下の通りである。
Example 9 <Synthesis of Compound of Formula 6b> A compound of Formula 6a (430 mg, 1.
26mM) was dissolved in a mixed solvent of 4: 1-tetrahydrofuran / acetonitrile (24 ml; 6 ml), and triphenylphosphine (990 mg, 3.77 mM) and imidazole (642 mg, 9.43) were dissolved.
mM) and iodine (960 mg, 7.54 mM) in that order.
Stirred for minutes. To this reaction solution was added a saturated aqueous solution of sodium hydrogen carbonate (10 ml), and the mixture was extracted twice with 120 ml of ether.
The combined organic layers were washed sequentially with 10% aqueous sodium sulfite solution (10 ml), saturated aqueous sodium hydrogen carbonate solution (10 ml) and saturated saline solution (10 ml), dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and a β-epoxy iodide represented by the formula 6b was obtained as a colorless oil from a fraction of ether / n-hexane (1:20).
486.3 mg (85% yield) were obtained. The spectrum data and elemental analysis result of the compound of the formula 6b are as follows.

【0037】 [α]D 31;−26.3°(C=1.19, クロロフォルム) IRνmax (neat)cm-1 ; 2956 , 2898 , 2856 , 2176 ,
1252 , 1099 , 840。1 H−NMR (300MHz , CDCl3); δ4.06〜 3.94 ( m, 1
H)3.21( dd, 1H, J=5. 9, 9.9Hz ), 3.13( dd, 1
H, J=5.9, 10.3Hz), 3.05(dt, 1H, J=1.8, 6.2Hz),
2.98(dt, 1H, J=1.8, 6.6Hz), 2.43(d, 2H, J=6.2H
z), 1.85( ddd,1H, J=5.1, 7.3, 13.9Hz), 1.73( d
dd, 1H, J=4.0, 7.0, 13.9Hz), 0.90( s, 9H), 0.14
( s, 9H), 0.11( s, 3H), 0.10( s, 3H)。 MS ; 395(M+ −57), 341(M+ −111 ), 283(M
+ −169 ),73( 100%)。 Anal. Calcd. for C17H33O2Si2I , C ; 45.12, H ; 7.
35, I ;28.04。 Found: C ; 45.03 , H ; 7.22 , I ; 27.90 。
[Α] D 31 ; −26.3 ° (C = 1.19, chloroform) IRνmax (neat) cm −1 ; 2956, 2898, 2856, 2176,
1252, 1099, 840. 1 H-NMR (300 MHz, CDCl 3 ); δ 4.06 to 3.94 (m, 1
H) 3.21 (dd, 1H, J = 5.9, 9.9Hz), 3.13 (dd, 1
H, J = 5.9, 10.3Hz), 3.05 (dt, 1H, J = 1.8, 6.2Hz),
2.98 (dt, 1H, J = 1.8, 6.6Hz), 2.43 (d, 2H, J = 6.2H
z), 1.85 (ddd, 1H, J = 5.1, 7.3, 13.9Hz), 1.73 (d
dd, 1H, J = 4.0, 7.0, 13.9Hz), 0.90 (s, 9H), 0.14
(S, 9H), 0.11 (s, 3H), 0.10 (s, 3H). MS; 395 (M + -57), 341 (M + -111), 283 (M
+ -169), 73 (100%). Anal.Calcd. For C 17 H 33 O 2 Si 2 I, C; 45.12, H; 7.
35, I; 28.04. Found: C; 45.03, H; 7.22, I; 27.90.

【0038】実施例10 <式6dの化合物の合成>式6cの化合物( 1.05g, 3.
89mM)の4 :1−テトラヒドロフラン/アセトニトリル
(70ml:18ml)溶液にトリフェニルホスフィン(3.06g,
11.67mM), イミダゾール(1.99g, 29.17mM), ヨウ素
(2.96g, 23.33mM)を順次加え、室温で30分間攪拌し
た。飾り英字計算―この反応液に飽和炭酸水素ナトリウ
ム水溶液(40ml)を加え、エーテル 200mlで2回抽出し
た。合わせた有機層を10%亜硫酸ナトリウム水溶液40m
l,飽和炭酸水素ナトリウム水溶液40ml、飽和食塩水40m
lで順次洗浄後、硫酸マグネシウムで乾燥し、減圧下に
溶媒を留去した。残渣をシリカゲルカラムクロマトグラ
フィーに付し、エーテル/n−ヘキサン(1:15)の留
分から無色油状の式6dで表されるβ−エポキシアイオ
ダイド 1.25g(収率84%)を得た。式6dの化合物のス
ペクトルデータおよび元素分析結果は以下の通りであ
る。
Example 10 <Synthesis of Compound of Formula 6d> Compound of formula 6c (1.05 g, 3.
89 mM) in a solution of 4: 1-tetrahydrofuran / acetonitrile (70 ml: 18 ml) was added to triphenylphosphine (3.06 g,
11.67 mM), imidazole (1.99 g, 29.17 mM) and iodine (2.96 g, 23.33 mM) were sequentially added, followed by stirring at room temperature for 30 minutes. Ornament calculation: A saturated aqueous solution of sodium hydrogen carbonate (40 ml) was added to the reaction solution, and the mixture was extracted twice with 200 ml of ether. The combined organic layer is 40m 10% sodium sulfite aqueous solution
l 、 Saturated sodium bicarbonate aqueous solution 40ml 、 saturated saline 40m
After successive washing with l, the resultant was dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 1.25 g (84% yield) of a colorless oily β-epoxy iodide represented by the formula 6d from a fraction of ether / n-hexane (1:15). The spectrum data and elemental analysis result of the compound of the formula 6d are as follows.

【0039】 [α]D 29;−26.9°(C=1.17, クロロフォルム) IRνmax (neat)cm-1 ; 3306 , 2954 , 2930 , 2888 ,
2856 , 2120 , 1255, 1099 。1 H−NMR (300MHz , CDCl3); δ4.04〜3.96( m, 1H)
3.22(dd, 1H, J=5.9,9.5Hz), 3.12(dd, 1H, J=5.9,
9.9Hz), 3.06(dt, 1H, J=1.8, 5.9Hz), 2.99(ddd,
1H, J=1.8, 4.8, 7.0Hz), 2.40(dd, 2H, J=2.6, 6.2H
z), 2.00(t,1H, J=2.6Hz)1.90( ddd, 1H, J=4.8,
7.7, 14.3Hz), 1.72( ddd, 1H, J=3.7, 7.0, 13.9H
z), 0.90( s, 9H), 0.11( s, 6H )。 MS ; 341(M+ −39), 255(M+ −125 ), 185(M
+ −195 ), 127(M+−253 ), 73( 100%)。 Anal. Calcd. for C14H25O2SiI ,C ; 44.21 , H ; 6.6
3 , I ; 33.37 。 Found: C ; 44.42 , H ; 6.73 , I ; 33.59 。
[Α] D 29 ; −26.9 ° (C = 1.17, chloroform) IRνmax (neat) cm −1 ; 3306, 2954, 2930, 2888,
2856, 2120, 1255, 1099. 1 H-NMR (300 MHz, CDCl 3 ); δ 4.04 to 3.96 (m, 1H)
3.22 (dd, 1H, J = 5.9,9.5Hz), 3.12 (dd, 1H, J = 5.9,
9.9Hz), 3.06 (dt, 1H, J = 1.8, 5.9Hz), 2.99 (ddd,
1H, J = 1.8, 4.8, 7.0Hz), 2.40 (dd, 2H, J = 2.6, 6.2H
z), 2.00 (t, 1H, J = 2.6Hz) 1.90 (ddd, 1H, J = 4.8,
7.7, 14.3Hz), 1.72 (ddd, 1H, J = 3.7, 7.0, 13.9H
z), 0.90 (s, 9H), 0.11 (s, 6H). MS; 341 (M + -39), 255 (M + -125), 185 (M
+ -195), 127 (M + -253), 73 (100%). Anal.Calcd. For C 14 H 25 O 2 SiI, C; 44.21, H; 6.6
3, I; 33.37. Found: C; 44.42, H; 6.73, I; 33.59.

【0040】実施例11 <式7aの化合物の合成>式6bの化合物( 456mg, 1.
01mM)のメタノール(14ml)溶液に、活性化した亜鉛
( 198mg, 3.03mM)と酢酸( 0.5ml)を順次室温で加
え、40℃に昇温して超音波に 1時間付した。この反応液
をエーテル70mlで希釈した後セライト濾過し、その瀘液
を5%塩酸水溶液10ml、飽和炭酸水素ナトリウム水溶液
(10ml)、飽和食塩水10mlで順次洗浄し、硫酸マグネシ
ウムで乾燥し、減圧下に溶媒を留去した。残渣をシリカ
ゲルカラムクロマトグラフィーに付し、エーテル/n−
ヘキサン(1:30)の留分から無色油状の式7aで表さ
れる化合物 287.2mg(収率87%)を得た。式7aの化合
物のスペクトルデータおよび元素分析結果は以下の通り
である。
Example 11 <Synthesis of Compound of Formula 7a> Compound of formula 6b (456 mg, 1.
Activated zinc (198 mg, 3.03 mM) and acetic acid (0.5 ml) were sequentially added to a solution of (01 mM) in methanol (14 ml) at room temperature, heated to 40 ° C., and subjected to ultrasonic waves for 1 hour. The reaction mixture was diluted with 70 ml of ether and filtered through celite, and the filtrate was washed successively with 10 ml of a 5% aqueous hydrochloric acid solution, 10 ml of a saturated aqueous sodium hydrogen carbonate solution (10 ml) and 10 ml of a saturated saline solution, dried over magnesium sulfate, and dried under reduced pressure. The solvent was distilled off. The residue was subjected to silica gel column chromatography to give ether / n-
From the fraction of hexane (1:30), 287.2 mg (87% yield) of a compound represented by the formula 7a was obtained as a colorless oil. The spectrum data and elemental analysis result of the compound of the formula 7a are as follows.

【0041】 [α]D 28;−26.0°( C=1.055, クロロフォルム) IRνmax (neat)cm-1 ; 3444 , 2954 , 2858 , 2176 ,
1250 , 1098。1 H− NMR(300MHz , CDCl3); δ5.86(ddd, 1H, J=4.
9, 10.4, 17.1Hz), 5.25(bd, 1H, J=17.1Hz), 5.08
(bd, 1H, J=10.4Hz), 4.43〜4.40( m, 1H),4.15〜
4.10( m ,1H), 2.88(d, 1H, J=3.1Hz), 2.47(d, 2
H, J=6.1Hz), 1.82( ddd, 1H, J=3.1, 6.1, 14.6H
z), 1.74( ddd, 1H, J=3.7, 9.8, 13.4Hz), 0.88(
s, 9H), 0.12( s, 9H), 0.10( s, 6H)。 MS ; 269(M+ −C4H9), 215 (M+ −111 ), 159
(M+ −167 ), 73( 100%)。 Anal. Calcd. for C17H34O2Si2 ,C ; 62.54 , H ; 1
0.50。 Found:C ; 62.63 , H ; 10.52 。
[Α] D 28 ; −26.0 ° (C = 1.055, chloroform) IRνmax (neat) cm −1 ; 3444, 2954, 2858, 2176,
1250, 1098. 1 H-NMR (300 MHz, CDCl 3 ); δ 5.86 (ddd, 1 H, J = 4.
9, 10.4, 17.1Hz), 5.25 (bd, 1H, J = 17.1Hz), 5.08
(Bd, 1H, J = 10.4Hz), 4.43 to 4.40 (m, 1H), 4.15 to
4.10 (m, 1H), 2.88 (d, 1H, J = 3.1Hz), 2.47 (d, 2
H, J = 6.1Hz), 1.82 (ddd, 1H, J = 3.1, 6.1, 14.6H
z), 1.74 (ddd, 1H, J = 3.7, 9.8, 13.4Hz), 0.88 (
s, 9H), 0.12 (s, 9H), 0.10 (s, 6H). MS; 269 (M + -C 4 H 9 ), 215 (M + -111), 159
(M + -167), 73 (100%). Anal. Calcd. For C 17 H 34 O 2 Si 2 , C; 62.54, H; 1
0.50. Found: C; 62.63, H; 10.52.

【0042】実施例12 <式7bの化合物の合成>式7aの化合物( 259.9mg,
0.80mM)のメタノール( 4.5ml)溶液に炭酸カリウム
( 275mg, 1.99mM)を室温で加え、40℃に昇温して1時
間攪拌した。この反応液の溶媒を減圧下に留去し、飽和
食塩水10mlを加え、エーテル70mlで2回抽出した。合わ
せた有機層を硫酸マグネシウムで乾燥し、減圧下溶媒留
去した。残渣をシリカゲルカラムクロマトグラフィーに
付し、エーテル/n−ヘキサン(1:2)の留分から無
色油状の式7bで表される化合物 196.5mg(収率97%)
を得た。
Example 12 <Synthesis of Compound of Formula 7b> Compound of formula 7a (259.9 mg,
To a solution of 0.80 mM) in methanol (4.5 ml) was added potassium carbonate (275 mg, 1.99 mM) at room temperature, and the mixture was heated to 40 ° C. and stirred for 1 hour. The solvent of this reaction solution was distilled off under reduced pressure, 10 ml of saturated saline was added, and the mixture was extracted twice with 70 ml of ether. The combined organic layer was dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and from the fraction of ether / n-hexane (1: 2), 196.5 mg (97% yield) of a compound represented by the formula 7b as a colorless oil was obtained.
I got

【0043】また、式7b化合物合成の別法として次の
方法により合成した。式6bの化合物( 1.24g, 3.26m
M)のメタノール(40ml)溶液に活性化した亜鉛( 640m
g, 9.79mM)と酢酸( 1ml)を順次室温で加え、40℃に
昇温して超音波に1時間付した。この反応液をエーテル
200mlで希釈した後セライト濾過し、その濾液を5 %塩
酸水溶液30ml、飽和炭酸水素ナトリウム水溶液30ml、飽
和食塩水30mlで順次洗浄し、硫酸マグネシウムで乾燥し
た後減圧下で溶媒を留去した。残渣をシリカゲルクロマ
トグラフィーに付し、エーテル/n−ヘキサン(1:
2)の留分から無色油状の式7bで表される化合物 720
mg(収率87%)を得た。式7bの化合物のスペクトルデ
ータおよび元素分析結果は以下の通りである。
The compound of the formula 7b was synthesized by the following method as another method. Compound of formula 6b (1.24 g, 3.26 m
Activated zinc (640m) in methanol (40ml) solution of M)
g, 9.79 mM) and acetic acid (1 ml) were sequentially added at room temperature, heated to 40 ° C., and subjected to ultrasonic wave for 1 hour. This reaction solution is
After dilution with 200 ml, the mixture was filtered through celite, and the filtrate was washed successively with 30 ml of a 5% aqueous hydrochloric acid solution, 30 ml of a saturated aqueous sodium hydrogen carbonate solution and 30 ml of a saturated saline solution, dried over magnesium sulfate and then the solvent was distilled off under reduced pressure. The residue was subjected to silica gel chromatography to give ether / n-hexane (1:
Compound 720 represented by the formula 7b as a colorless oil from the fraction of 2)
mg (87% yield). The spectrum data and elemental analysis result of the compound of the formula 7b are as follows.

【0044】 [α]D 27;−32.3°(C=1.15, クロロフォルム) IRνmax (neat)cm-1 ; 3446 , 3312 , 2954 , 2932 ,
2858 , 1256 , 1098, 837 , 774 。1 H−NMR (300MHz , CDCl3); δ5.89(ddd, 1H, J=5.
5, 10.3, 16.9Hz), 5.27( dt, 1H, J=17.2, 1.1Hz),
5.10( dt, 1H, J=10.3, 1.5Hz), 4.47〜4.37( m, 1
H), 4.21〜4.10( m, 1H), 2.72(d, 1H, J=3.3Hz),
2. 45(dd, 2H,J=2.9, 6.6Hz), 2.01(t, 1H, J=2.8H
z), 1.90〜1.72( m, 2H), 0.90( s,9H), 0.12(
s, 6H)。 MS ;255 (M+ +H+ ), 197(M+ −C4H9), 75( 1
00%)。 Anal. Calcd. for C14H26O2Si ,C ; 66.09 , H ; 10.3
0 。 Found: C ; 65.83 , H ; 10.43。
[Α] D 27 ; −32.3 ° (C = 1.15, chloroform) IRνmax (neat) cm −1 ; 3446, 3312, 2954, 2932,
2858, 1256, 1098, 837, 774. 1 H-NMR (300 MHz, CDCl 3 ); δ 5.89 (ddd, 1 H, J = 5.
5, 10.3, 16.9Hz), 5.27 (dt, 1H, J = 17.2, 1.1Hz),
5.10 (dt, 1H, J = 10.3, 1.5Hz), 4.47 to 4.37 (m, 1
H), 4.21-4.10 (m, 1H), 2.72 (d, 1H, J = 3.3Hz),
2.45 (dd, 2H, J = 2.9, 6.6Hz), 2.01 (t, 1H, J = 2.8H
z), 1.90-1.72 (m, 2H), 0.90 (s, 9H), 0.12 (
s, 6H). MS; 255 (M + + H + ), 197 (M + -C 4 H 9 ), 75 (1
00%). Anal.Calcd. For C 14 H 26 O 2 Si, C; 66.09, H; 10.3
0. Found: C; 65.83, H; 10.43.

【0045】実施例13 <式7cの化合物の合成>式7bの化合物( 164.6mg,
0.65mM)のジメチルフォルムアミド( 2ml)溶液にイミ
ダゾール( 168mg, 2.46mM)、触媒量の4−ジメチルア
ミノピリジン、t−ブチルジメチルシリルクロライド
( 156mg, 1.04mM)を順次加え、室温で12時間攪拌し
た。この反応液に水 5mlを加え、エーテル40mlで2回抽
出した。合わせた有機層を飽和食塩水 5mlで洗浄し、硫
酸マグネシウムで乾燥し、減圧下溶媒留去した。残渣を
シリカゲルカラムクロマトグラフィーに付し、エーテル
/n−ヘキサン(1:30)の留分から無色油状の式7c
で表される化合物 224.9mg(収率94%)を得た。式7c
の化合物のスペクトルデータおよび元素分析結果は以下
の通りである。
Example 13 <Synthesis of Compound of Formula 7c> A compound of formula 7b (164.6 mg,
Imidazole (168 mg, 2.46 mM), a catalytic amount of 4-dimethylaminopyridine, and t-butyldimethylsilyl chloride (156 mg, 1.04 mM) were sequentially added to a solution of 0.65 mM) in dimethylformamide (2 ml), and the mixture was stirred at room temperature for 12 hours. did. 5 ml of water was added to the reaction solution, and extracted twice with 40 ml of ether. The combined organic layer was washed with 5 ml of saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and a fraction of ether / n-hexane (1:30) was converted to a colorless oil of the formula 7c
224.9 mg (yield 94%) of the compound represented by were obtained. Equation 7c
The spectrum data and elemental analysis result of the compound are as follows.

【0046】 [α]D 30;−10.3°(C=1.50, クロロフォルム) IRνmax (neat)cm-1 ; 3316 , 2956 , 2932 , 2890 ,
2858 , 1254 , 1091, 835 , 772 。1 H−NMR (300MHz , CDCl3); δ5.82(ddd, 1H, J=7.
3, 10.3, 17.3Hz), 5.14(bd, 1H, J=16.9Hz), 5.04
(bd, 1H, J=10.3Hz), 4.22(dt, 1H, J=5.5, 7.0H
z), 3.98〜3.88( m, 1H), 2.40〜2.32( m, 2H),
1.98(t, 1H, J=2.4Hz), 1.88( ddd, 1H, J=5.1, 7.
3, 13.2Hz), 1.65( ddd, 1H, J=5.1, 6.2, 13.6Hz),
0.89(s, 18H), 0.09( s, 6H), 0.06( s, 3H),
0.04( s, 3H)。 MS ; 311(M+ −C4H9), 171( 100%), 73( 100
%)。 Anal. Calcd. for C20H40O2Si2 ,C ; 65.17 , H ; 1
0.95 。 Found: C ; 64.99 , H ; 10.93。
[Α] D 30 ; -10.3 ° (C = 1.50, chloroform) IRνmax (neat) cm −1 ; 3316, 2956, 2932, 2890,
2858, 1254, 1091, 835, 772. 1 H-NMR (300 MHz, CDCl 3 ); δ 5.82 (ddd, 1 H, J = 7.
3, 10.3, 17.3Hz), 5.14 (bd, 1H, J = 16.9Hz), 5.04
(Bd, 1H, J = 10.3Hz), 4.22 (dt, 1H, J = 5.5, 7.0H
z), 3.98-3.88 (m, 1H), 2.40-2.32 (m, 2H),
1.98 (t, 1H, J = 2.4Hz), 1.88 (ddd, 1H, J = 5.1, 7.
3, 13.2Hz), 1.65 (ddd, 1H, J = 5.1, 6.2, 13.6Hz),
0.89 (s, 18H), 0.09 (s, 6H), 0.06 (s, 3H),
0.04 (s, 3H). MS; 311 (M + -C 4 H 9), 171 (100%), 73 (100
%). Anal. Calcd. For C 20 H 40 O 2 Si 2 , C; 65.17, H; 1
0.95. Found: C; 64.99, H; 10.93.

【0047】実施例14 <式8aの化合物の合成>式7cの化合物( 202mg, 0.
55mM)のテトラヒドロフラン(4ml)溶液に−78℃で1.
4M n−ブチルリチウム/n−ヘキサン溶液(0.47ml,
0.66mM)を徐々に滴下し、40分間同温度で攪拌した。−
78℃でこの反応液にクロル炭酸メチル(0.08ml, 0.77m
M)を徐々に滴下し、2時間攪拌した。この反応液を0
℃まで昇温して飽和塩化アンモニウム水溶液1mlを加え
て20分間攪拌して室温まで昇温した。この反応液に水10
mlを加え、エーテル70mlで2回抽出後、有機層を合わ
せ、飽和食塩水10mlで洗浄し、硫酸マグネシウムで乾燥
し、減圧下溶媒留去した。残渣をシリカゲルカラムクロ
マトグラフィーに付し、エーテル/n−ヘキサン(1:
80)の留分から無色油状の式8aで表される化合物 18
1.2mg(収率78%)を得た。式8aの化合物のスペクト
ルデータおよび元素分析結果は以下の通りである。
Example 14 <Synthesis of Compound of Formula 8a> A compound of Formula 7c (202 mg, 0.2 g
55 mM) in tetrahydrofuran (4 ml) at -78 ° C.
4M n-butyllithium / n-hexane solution (0.47 ml,
0.66 mM) was gradually added dropwise, and the mixture was stirred at the same temperature for 40 minutes. −
At 78 ° C, add methyl chlorocarbonate (0.08ml, 0.77m
M) was slowly added dropwise and stirred for 2 hours. This reaction solution is
The temperature was raised to 0 ° C., 1 ml of a saturated aqueous solution of ammonium chloride was added, and the mixture was stirred for 20 minutes and heated to room temperature. Water 10
After adding twice with 70 ml of ether, the organic layers were combined, washed with 10 ml of saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and ether / n-hexane (1:
80) The compound of the formula 8a which is a colorless oil from the fraction of 18)
1.2 mg (78% yield) were obtained. The spectrum data and elemental analysis result of the compound of the formula 8a are as follows.

【0048】 [α]D 28;− 4.7°( C=1.145, クロロフォルム) IRνmax (neat)cm-1 ; 2954 , 2932 , 2890 , 2858 ,
2240 , 1721 , 1255, 1077 , 837 , 773。1 H−NMR (300MHz , CDCl3); δ5.80(ddd, 1H, J=7.
3, 10.3, 17.2Hz), 5.14(bd, 1H, J=17.2Hz), 5.05
(bd, 1H, J=10.3Hz), 4.21(dt, 1H, J=5.5, 7.0H
z), 4.07〜3.92( m, 1H), 3.75( m, 3H), 2.56(
dd, 1H, J=5.5, 16.8Hz), 2.46( dd, 1H, J=5.5, 17.
2Hz), 1.82( ddd, 1H, J=5.9, 7.3, 13.2Hz), 1.70
( dt, 1H, J=13.9, 5.5Hz), 0.89(s, 18H), 0.10
( s, 3H), 0.09( s, 3H), 0.06( s, 3H), 0.04
( s, 3H)。 MS ; 411(M+ −15), 369 (M+ −57), 171 (100
%), 147 (M+ − 279), 73(100 %)。 Anal. Calcd. for C22H42O4Si2, C ; 61.93 , H ; 9.
93。 Found: C ; 61.79 , H ; 10.03。
[Α] D 28 ; −4.7 ° (C = 1.145, chloroform) IRνmax (neat) cm −1 ; 2954, 2932, 2890, 2858,
2240, 1721, 1255, 1077, 837, 773. 1 H-NMR (300 MHz, CDCl 3 ); δ 5.80 (ddd, 1 H, J = 7.
3, 10.3, 17.2Hz), 5.14 (bd, 1H, J = 17.2Hz), 5.05
(Bd, 1H, J = 10.3Hz), 4.21 (dt, 1H, J = 5.5, 7.0H
z), 4.07-3.92 (m, 1H), 3.75 (m, 3H), 2.56 (
dd, 1H, J = 5.5, 16.8Hz), 2.46 (dd, 1H, J = 5.5, 17.
2Hz), 1.82 (ddd, 1H, J = 5.9, 7.3, 13.2Hz), 1.70
(Dt, 1H, J = 13.9, 5.5Hz), 0.89 (s, 18H), 0.10
(S, 3H), 0.09 (s, 3H), 0.06 (s, 3H), 0.04
(S, 3H). MS; 411 (M + -15), 369 (M + -57), 171 (100
%), 147 (M + -279), 73 (100%). Anal.Calcd. For C 22 H 42 O 4 Si 2 , C; 61.93, H; 9.
93. Found: C; 61.79, H; 10.03.

【0049】実施例 15 <式8bの化合物の合成>式7cの化合物( 500mg, 1.
36mM)のテトラヒドロフラン(10ml)溶液に−78℃で1.
4M n−ブチルリチウム/n−ヘキサン溶液( 1.2ml,
1.63mM)を徐々に滴下し、40分間同温度で攪拌した。−
78℃でこの反応液にクロル炭酸エチル( 0.2ml, 1.90m
M)を徐々に滴下し、 2.5時間攪拌した。この反応液を
0℃まで昇温して飽和塩化アンモニウム水溶液 2mlを加
えて20分間攪拌して室温まで昇温した。この反応液に水
20mlを加え、エーテル 150mlで 2回抽出後、有機層を合
わせ、飽和食塩水20mlで洗浄し、硫酸マグネシウムで乾
燥し、減圧下溶媒留去した。残渣をシリカゲルカラムク
ロマトグラフィーに付し、エーテル/n−ヘキサン
(1:30)の留分から無色油状の式8bで表される化合
物 482.1mg(収率81%)を得た。式8bの化合物のスペ
クトルデータおよび元素分析結果は以下の通りである。
Example 15 <Synthesis of Compound of Formula 8b> A compound of Formula 7c (500 mg, 1.
36 mM) in tetrahydrofuran (10 ml) at -78 ° C.
4M n-butyllithium / n-hexane solution (1.2ml,
1.63 mM) was gradually added dropwise, followed by stirring at the same temperature for 40 minutes. −
Ethyl chlorocarbonate (0.2ml, 1.90m
M) was slowly added dropwise, followed by stirring for 2.5 hours. The temperature of the reaction solution was raised to 0 ° C., 2 ml of a saturated aqueous solution of ammonium chloride was added, and the mixture was stirred for 20 minutes and heated to room temperature. Add water to the reaction
After adding 20 ml and extracting twice with 150 ml of ether, the organic layers were combined, washed with 20 ml of saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 482.1 mg (yield: 81%) of a compound represented by the formula 8b as a colorless oil from a fraction of ether / n-hexane (1:30). The spectrum data and elemental analysis result of the compound of the formula 8b are as follows.

【0050】 [α]D 25;− 3.5°(C=1.23, クロロフォルム) IRνmax (neat)cm-1 ; 2956 , 2932 , 2856 , 2236 ,
1715 , 1252 , 1073, 836 , 773 。1 H−NMR (300MHz , CDCl3); δ5.80(ddd, 1H, J=7.
3, 10.3, 17.2Hz), 5.14(bd, 1H, J=17.2Hz), 5.05
(bd, 1H, J=10.3Hz), 4.24〜4.17( m, 3H),3.98(
dt, 1H, J=5.9, 11.7Hz), 2.56( dd, 1H, J=5.5, 16.
9Hz), 2.46( dd, 1H, J=5.9, 17.2Hz), 1.82( ddd,
1H, J=5.9, 7.3, 13.2Hz), 1.70( dt,1H, J=13.9,
5.5Hz), 1.30(t, 3H, J=7.1Hz), 0.89(s, 18H),
0.10( s,3H), 0.09( s, 3H), 0.06( s, 3H), 0.0
4( s, 3H)。 MS ; 425(M+ −15), 383 (M+ −57), 171( 100
%),147(M− 279),73( 100%)。 Anal. Calcd. for C23H44O4Si2, C ; 62.67 , H ; 1
0.06 。 Found: C ; 62.70 , H ; 10.06。
[Α] D 25 ; −3.5 ° (C = 1.23, chloroform) IRνmax (neat) cm −1 ; 2956, 2932, 2856, 2236,
1715, 1252, 1073, 836, 773. 1 H-NMR (300 MHz, CDCl 3 ); δ 5.80 (ddd, 1 H, J = 7.
3, 10.3, 17.2Hz), 5.14 (bd, 1H, J = 17.2Hz), 5.05
(Bd, 1H, J = 10.3Hz), 4.24 to 4.17 (m, 3H), 3.98 (
dt, 1H, J = 5.9, 11.7Hz), 2.56 (dd, 1H, J = 5.5, 16.
9Hz), 2.46 (dd, 1H, J = 5.9, 17.2Hz), 1.82 (ddd,
1H, J = 5.9, 7.3, 13.2Hz), 1.70 (dt, 1H, J = 13.9,
5.5Hz), 1.30 (t, 3H, J = 7.1Hz), 0.89 (s, 18H),
0.10 (s, 3H), 0.09 (s, 3H), 0.06 (s, 3H), 0.0
4 (s, 3H). MS; 425 (M + -15), 383 (M + -57), 171 (100
%), 147 (M-279), 73 (100%). Anal. Calcd. For C 23 H 44 O 4 Si 2 , C; 62.67, H; 1
0.06. Found: C; 62.70, H; 10.06.

【0051】実施例16 <式9aの化合物の合成>式8aの化合物(35mg, 82.2
μ )のベンゼン( 2ml)溶液に亜リン酸トリメチル
( 8.3μl,70.4μ ),Pd2(dba )3 ・CHCl3 (17mg,
16.4μM 、dbaはジベンジリデンアセトンの略称であ
る。以下の例に於ても同じ。), 酢酸(1μl ,1.7μM
)を室温で順次加え、同温度で12時間、窒素雰囲気下
で攪拌した。この溶媒留去後、残渣をシリカゲルカラム
クロマトグラフィーに付し、エーテル/n−ヘキサン
(1:20)の留分から無色油状の式9aで表される化合
物22.3mg(収率64%)を得た。式9aの化合物のスペク
トルデータおよび元素分析結果は以下の通りである。
Example 16 <Synthesis of Compound of Formula 9a> Compound of formula 8a (35 mg, 82.2
μ) in benzene (2 ml) solution, trimethyl phosphite (8.3 μl, 70.4 μ), Pd 2 (dba) 3 · CHCl 3 (17 mg,
16.4 μM, dba is an abbreviation for dibenzylideneacetone. The same applies to the following examples. ), Acetic acid (1μl, 1.7μM
) Were sequentially added at room temperature, and the mixture was stirred at the same temperature for 12 hours under a nitrogen atmosphere. After evaporation of the solvent, the residue was subjected to silica gel column chromatography to obtain 22.3 mg (yield: 64%) of a compound represented by the formula 9a as a colorless oil from a fraction of ether / n-hexane (1:20). . The spectrum data and elemental analysis result of the compound of the formula 9a are as follows.

【0052】IRνmax (neat)cm-1 ; 2930 , 2856 , 1
721 , 1642 , 1471 。1 H−NMR (500MHz , CDCl3); δ5.89( s, 1H), 5.07
(bs, 1H), 5.05(bs, 1H), 4.58〜4.53( m, 1H),
4.27〜4.19( m, 1H), 3.68( s, 3H), 3.33( dd, 1
H, J=5.2, 14.7Hz), 2.67(bd, 1H, J=14.7Hz), 1.98
〜1.89( m, 1H), 1.80〜1.70( m, 1H)0.88( s, 9
H), 0.84( s, 9H), 0.04(s, 12H)。13 C−NMR (125MHz , CDCl3); δ 167.02 , 157.48 ,
152.08 , 116.06 , 109.96 , 70.22 , 67.14 , 51.07
, 43.73 , 37.58 , 25.87 , 25.76 , 18.31 ,18.12 ,
−4.93 ,−5.00。 MS ; 411(M+ −15), 395 (M+ −31), 369 (M+
−57), 73( 100%)。
IRνmax (neat) cm -1 ; 2930, 2856, 1
721, 1642, 1471. 1 H-NMR (500 MHz, CDCl 3 ); δ 5.89 (s, 1 H), 5.07
(Bs, 1H), 5.05 (bs, 1H), 4.58 to 4.53 (m, 1H),
4.27 to 4.19 (m, 1H), 3.68 (s, 3H), 3.33 (dd, 1
H, J = 5.2, 14.7Hz), 2.67 (bd, 1H, J = 14.7Hz), 1.98
Up to 1.89 (m, 1H), 1.80 to 1.70 (m, 1H) 0.88 (s, 9
H), 0.84 (s, 9H), 0.04 (s, 12H). 13 C-NMR (125 MHz, CDCl 3 ); δ 167.02, 157.48,
152.08, 116.06, 109.96, 70.22, 67.14, 51.07
, 43.73, 37.58, 25.87, 25.76, 18.31, 18.12,
−4.93, −5.00. MS; 411 (M + -15), 395 (M + -31), 369 (M +
-57), 73 (100%).

【0053】実施例17 <式9bの化合物の合成>式8bの化合物(30mg, 68.2
μM )のベンゼン( 2ml)溶液にエチレンビス(ジフェ
ニルフォスフィン(2.7mg, 6.8μM ), Pd2 (dba )3
・CHCl3 (14mg,13.5μM ), ピバリン酸( 4μl , 34.
1μM )を室温で順次加え、50℃に昇温して15時間、窒
素雰囲気下で攪拌した。溶媒留去後、残渣をシリカゲル
カラムクロマトグラフィーに付し、エーテル/n−ヘキ
サン( 1:20)の留分から無色油状の式9bで表される
化合物21.1mg(収率69%)を得た。式9bの化合物のス
ペクトルデータは以下の通りである。
Example 17 <Synthesis of Compound of Formula 9b> Compound of formula 8b (30 mg, 68.2)
μM) in benzene (2 ml) solution and ethylenebis (diphenylphosphine (2.7 mg, 6.8 μM), Pd 2 (dba) 3
・ CHCl 3 (14mg, 13.5μM), pivalic acid (4μl, 34.
1 μM) at room temperature, and the mixture was heated to 50 ° C. and stirred under a nitrogen atmosphere for 15 hours. After evaporating the solvent, the residue was subjected to silica gel column chromatography to obtain 21.1 mg (yield: 69%) of a compound represented by the formula 9b as a colorless oil from a fraction of ether / n-hexane (1:20). The spectral data of the compound of formula 9b is as follows.

【0054】1H−NMR (300MHz , CDCl3); δ5.89( b
rs, 1H), 5.07(t, 1H, J=1.8Hz), 5.06(t, 1H, J=
1.8Hz), 4.57〜4.54( m, 1H), 4.26〜4.22( m, 1
H), 4.18〜4.10( m, 2H), 3.36( dd, 1H, J=5.5, 1
4.7Hz), 2.64( dt, 1H, J=2.4, 14.7Hz), 1.97〜1.9
2( m, 1H), 1.75(ddd, 1H, J= 1.8, 9.2, 11.6Hz),
1.26(t, 3H, J=7.3Hz), 0.85( s, 9H), 0.04(s, 1
2H)。
1 H-NMR (300 MHz, CDCl 3 ); δ 5.89 (b
rs, 1H), 5.07 (t, 1H, J = 1.8Hz), 5.06 (t, 1H, J =
1.8Hz), 4.57 to 4.54 (m, 1H), 4.26 to 4.22 (m, 1
H), 4.18 to 4.10 (m, 2H), 3.36 (dd, 1H, J = 5.5, 1
4.7Hz), 2.64 (dt, 1H, J = 2.4, 14.7Hz), 1.97-1.9
2 (m, 1H), 1.75 (ddd, 1H, J = 1.8, 9.2, 11.6Hz),
1.26 (t, 3H, J = 7.3Hz), 0.85 (s, 9H), 0.04 (s, 1
2H).

【0055】[0055]

【発明の効果】本発明は、骨粗髪症その他の疾病に対す
る治療薬カルシトリオール及びその関連のビタミン誘導
体を製造する際のA環部に相当する重要中間体を効率よ
く簡単な反応経路で得ることのできる原料化合物として
重要である。
INDUSTRIAL APPLICABILITY According to the present invention, an important intermediate corresponding to the A ring portion in the production of calcitriol and its related vitamin derivatives for the treatment of osteoporosis and other diseases can be obtained efficiently and in a simple reaction route. It is important as a raw material compound that can be used.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI C07F 7/18 C07F 7/18 F S W // C07D 303/20 C07D 303/20 (58)調査した分野(Int.Cl.6,DB名) C07C 33/04 C07C 29/56 CA(STN) REGISTRY(STN)──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification symbol FI C07F 7/18 C07F 7/18 FSW // C07D 303/20 C07D 303/20 (58) Investigated field (Int.Cl. 6 , DB name) C07C 33/04 C07C 29/56 CA (STN) REGISTRY (STN)

Claims (4)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 式1で表される化合物S−5−ヒドロキ
シ−オクタ−2,7−ジイン−1−オール及びそのシリ
ル誘導体。 【化1】 (但しR1 は水素もしくはトリメチルシリル基を,R2
は水素もしくはt−ブチルジメチルシリル基を, R3
テトラヒドロピラニル基もしくは水素を表す。)
1. A compound S-5-hydroxy-octa-2,7-diyn-1-ol represented by the formula 1 and a silyl derivative thereof. Embedded image (However, R 1 represents hydrogen or a trimethylsilyl group; R 2
Represents hydrogen or a t-butyldimethylsilyl group, and R 3 represents a tetrahydropyranyl group or hydrogen. )
【請求項2】 式1のR1 がトリメチルシリル基、R2
が水素及びR3 がテトラヒドロピラニル基である請求項
1記載の化合物。
2. R 1 of the formula 1 is a trimethylsilyl group, R 2
Is a hydrogen and R 3 is a tetrahydropyranyl group.
【請求項3】 式2で表される化合物S−5−トリメチ
ルシリル−1,2−オキシラニルペンタ−4−インをプ
ロパルギルテトラヒドロピラニルエーテルおよびn−ブ
チルリチウムと反応させることを特徴とする請求項2記
載の化合物の製法。 【化2】 (但し、TMS はトリメチルシリル基を表す)
3. The method according to claim 2, wherein the compound of formula 2 is reacted with propargyl tetrahydropyranyl ether and n-butyllithium. 2. A method for producing the compound according to 2. Embedded image (However, TMS represents a trimethylsilyl group)
【請求項4】 式3で表される化合物R−5,6−オキ
シラニルヘキサ−2−イニルテトラヒドロピラニルエー
テルをトリメチルシリルアセチレン、n−ブチルリチウ
ムと反応させることを特徴とする請求項2記載の化合物
の製法。 【化3】 (但し、THP はテトラヒドロピラニル基を表す)
4. The compound according to claim 2, wherein the compound R-5,6-oxiranylhex-2-ynyltetrahydropyranyl ether of the formula 3 is reacted with trimethylsilylacetylene and n-butyllithium. Preparation of the compound of Embedded image (However, THP represents a tetrahydropyranyl group)
JP21394494A 1994-09-07 1994-09-07 Calcitriol intermediate and process for producing the same Expired - Fee Related JP2929943B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21394494A JP2929943B2 (en) 1994-09-07 1994-09-07 Calcitriol intermediate and process for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21394494A JP2929943B2 (en) 1994-09-07 1994-09-07 Calcitriol intermediate and process for producing the same

Publications (2)

Publication Number Publication Date
JPH0873390A JPH0873390A (en) 1996-03-19
JP2929943B2 true JP2929943B2 (en) 1999-08-03

Family

ID=16647640

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21394494A Expired - Fee Related JP2929943B2 (en) 1994-09-07 1994-09-07 Calcitriol intermediate and process for producing the same

Country Status (1)

Country Link
JP (1) JP2929943B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE527228T1 (en) * 2008-05-20 2011-10-15 Firmenich & Cie METHOD FOR PRODUCING BETA-SANTALOL AND DERIVATIVES THEREOF

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
畑山範 "活性型ビタミンD▲下3▼A環部の簡便合成法の開発"日本薬学会第114年講演要旨集2(平成6年3月5日発行)

Also Published As

Publication number Publication date
JPH0873390A (en) 1996-03-19

Similar Documents

Publication Publication Date Title
CN104350035B (en) The improved method for preparing UT-15 and its derivative
Hall et al. Transannular Diels-Alder/Intramolecular Aldol Tandem Reaction as a Stereocontrolled Route to (+)-Aphidicolin and its Isosteric C8-Epimer1
JPH0251559B2 (en)
US7345181B2 (en) Process for preparing prostaglandin derivatives and starting materials for the same
JP2929943B2 (en) Calcitriol intermediate and process for producing the same
US5677467A (en) Synthesis of acetogenins
JP6872583B2 (en) Lubiprostone preparation method and its intermediates
Bates et al. Total synthesis of the cholesterol biosynthesis inhibitor 1233A via a (π-allyl) tricarbonyliron lactone complex
Murga et al. Erythrulose derivatives as functionalized chiral d3 and d4 synthons
Meshram et al. Total synthesis of nonenolide
JP2756608B2 (en) Method for producing optically active isoxazole derivative, intermediate for producing the same, and method for producing the same
KR20180090990A (en) Method for total synthesis of resolvable bean E1
JPS61126048A (en) Production of optically active 4-hydroxy-2-cyclopentenone
JP3883263B2 (en) Asymmetric synthesis of macrocarpals
JP2654834B2 (en) Optically active vinyl compound, intermediate for producing the same, and method for producing them
JP2503040B2 (en) α-Substituted-γ-alkoxyallyl sulfide derivative and method for producing the same
CN111662318A (en) Iloprost key intermediate and preparation method thereof
JP2011519903A (en) Preparation method of oreganoic acid
JP2743798B2 (en) Preparation of optically active compounds
JP2001247512A (en) Method of synthesizing alpha-ketol unsaturated fatty acid
WO1991008186A1 (en) Substituted open-chain terpene compound
JPH027578B2 (en)
JPH04321641A (en) Production of terpene alpha-ketols
WO1991008187A1 (en) Open-chain terpene compound
JPH0651694B2 (en) Optically active compound

Legal Events

Date Code Title Description
FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090521

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 10

Free format text: PAYMENT UNTIL: 20090521

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 11

Free format text: PAYMENT UNTIL: 20100521

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 11

Free format text: PAYMENT UNTIL: 20100521

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 12

Free format text: PAYMENT UNTIL: 20110521

LAPS Cancellation because of no payment of annual fees